Skip to main content
Premium Trial:

Request an Annual Quote

Rob Thomas and Metin Colpan

Premium

Benitec said last week that it has appointed as non-executive director and deputy chairman of its board Rob Thomas.

Thomas, said Benitec, is currently chairman of Citigroup Global Corporate & Investment Bank, Australia and New Zealand. He previously served as managing director of County NatWest Securities Australia, and became CEO, Australia and New Zealand of Salomon Smith Barney when it acquired CNWSAL.

“Having someone of [Thomas’] stature as deputy chairman brings greater independence, strength, and credibility to the board,” Benitec chairman and CEO John McKinley said in a statement. “His particular expertise in global capital markets will be of tremendous assistance to Benitec as it expands first into the USA and then on a worldwide basis.”


MorphoSys said this week that its shareholders have confirmed the appointment of Metin Colpan to the company’s supervisory board.

Colpin was most recently co-founder, CEO, and managing director of Qiagen, and replaces Jorg Reinhardt of Novartis Pharma at MorphoSys.

“Colpan’s experience in building Qiagen into one of the world’s leading biotechnology companies will be invaluable for MorphoSys to foster our new business initiative in the reagent field, Antibodies by Design,” MorphoSys CEO Simon Moroney said in a statement.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.